Hepatitis B vaccination in HIV-infected youth: A randomized trial of three regimens

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 4, 2011, Pages 325-332

  Flynn, Patricia M ^a,b   Cunningham, Coleen K ^c   Rudy, Bret ^d   Wilson, Craig M ^e   Kapogiannis, Bill ^f   Worrell, Carol ^f   Bethel, James ^g   Monte, Dina ^g   Bojan, Kelly ^h  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^g WESTAT   (United States)

^h The CORE Center   (United States)

Author keywords

adolescents; Engerix B; hepatitis B vaccination; HIV; Twinrix

Indexed keywords

HEPATITIS A HEPATITIS B VACCINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RECOMBINANT HEPATITIS B VACCINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADOLESCENT; ADULT; ARTHRALGIA; ARTICLE; ASTHENIA; CD4 LYMPHOCYTE COUNT; CHILD; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEPATITIS B; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MALE; MYALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SCHOOL CHILD; SOMNOLENCE; SYNCOPE; VACCINATION;

ADOLESCENT; BELGIUM; FEMALE; HEPATITIS A VACCINES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HIV INFECTIONS; HUMANS; IMMUNIZATION, SECONDARY; MALE; VACCINATION; VACCINES, COMBINED; YOUNG ADULT;

EID: 79952405697     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318203e9f2     Document Type: Article

References (39)

1. Arrazola MP, de Juanes JR, Ramos JT, et al. Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus. J Med Virol. 1995;45:339-341.
2. Diamant EP, Schechter C, Hodes DS, et al. Immunogenicity of hepatitis B vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1993;12:877-878. (Pubitemid 23311601)
3. Rutstein RM, Rudy B, Codispoti C, et al. Response to hepatitis B immunization by infants exposed to HIV. AIDS. 1994;8:1281-1284. (Pubitemid 24267751)
4. Scolfaro C, Fiammengo P, Balbo L, et al. Hepatitis B vaccination in HIV- 1-infected children: double efficacy doubling the paediatric dose. AIDS. 1996;10:1169-1170. (Pubitemid 26283357)
5. Zuccotti GV, Riva E, Flumine P, et al. Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus. J Pediatr. 1994; 125:70-72. (Pubitemid 24225181)
6. Zuin G, Principi N, Tornaghi R, et al. Impaired response to hepatitis B vaccine in HIV infected children. Vaccine. 1992;10:857-860.
7. Bruguera M, Cremades M, Salinas R, et al. Impaired response to recombinant hepatitis B vaccine in HIV-infected persons. J Clin Gastroenterol. 1992;14:27-30.
8. Carne CA, Weller IV, Waite J, et al. Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine. BMJ. 1987;294:866-868. (Pubitemid 17046382)
9. Collier AC, Corey L, Murphy VL, et al. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med. 1988;109:101-105.
10. Keet IP, van Doornum G, Safary A, et al. Insufficient response to hepatitis B vaccination in HIV-positive homosexual men. AIDS. 1992;6: 509-510.
11. Loke RH, Murray-Lyon IM, Coleman JC, et al. Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: an indicator of poor prognosis. J Med Virol. 1990;31:109-111. (Pubitemid 20213237)
12. Rey D, Krantz V, Partisani M, et al. Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Vaccine. 2000;18:1161-1165. (Pubitemid 30001829)
13. Rodrigo JM, Serra MA, Aparisi L, et al. Immune response to hepatitis B vaccine in parenteral drug abusers. Vaccine. 1992;10:798-801.
14. Tayal SC, Sankar KN. Impaired response to recombinant hepatitis B vaccine in asymptomatic HIV-infected individuals. AIDS. 1994;8:558-559. (Pubitemid 24102312)
15. Wong EK, Bodsworth NJ, SladeMA, et al. Response to hepatitis B vaccination in a primary care setting: influence of HIV infection, CD4+ lymphocyte count and vaccination schedule. Int J STD AIDS. 1996;7:490-494. (Pubitemid 27037409)
16. Tedaldi EM, Baker RK, Moorman AC, et al. Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis. 2004 15;38:1478-1484. (Pubitemid 38678612)
17. Landrum ML, Huppler Hullsiek K, Ganesan A, et al. Hepatitis B vaccine responses in a large US military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count. Vaccine. 2009;27:4731-4738.
18. Fonseca MO, Pang LW, de Paula Cavalheiro N, et al. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. Vaccine. 2005;23:2902-2908. (Pubitemid 40386492)
19. Cruciani M, Mengoli C, Serpelloni G, et al. Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients. Vaccine. 2009;27:17-22.
20. Overton ET, Sungkanuparph S, Powderly WG, et al. Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIVinfected persons. Clin Infect Dis. 200541:1045-1048.
21. Paitoonpong L, Suankratay C. Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy. Scand J Infect Dis. 2008;40:54-58.
22. Kim HN, Harrington RD, Van Rompaey SE, et al. Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons. Int J STD AIDS. 2008;19:600-604.
23. Bailey CL, Smith V, Sands M. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults. Int J Infect Dis. 2008;12:e77-e83.
24. Cornejo-Juárez P, Volkow-Fernández P, Escobedo-López K, et al. Randomized controlled trial of hepatitis B virus vaccine in HIV-1- infected patients comparing two different doses. AIDS Res Ther. 2006;3:9.
25. Wilson CM, Ellenberg JH, Sawyer MK, et al. Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort. Reaching for Excellence in Adolescent Care and Health. J Adoles Health. 2001;29:123-129. (Pubitemid 32799168)
26. Diaz-Mitoma F, Law B, Parsons J. A combined vaccine against hepatitis A and B in children and adolescents. Pediatr Infect Dis J. 1999;18:109-114. (Pubitemid 29101882)
27. Ambrosch F,Wiedermann G, Andre FE, et al. Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine. J Med Virol. 1994;44:452-456.
28. Van Herck K, Van Damme P, Collard F, et al. Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years. Scand J Gastroenterol. 1999;34:1236-1240. (Pubitemid 30026728)
29. KnollA,Hottentrager B,Kainz J, et al. Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults. Vaccine. 2000;18:2029-2032. (Pubitemid 30114347)
30. Lachin J. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials. 1981;2:93-114.
31. de Vries-Sluijs TE, Hansen BE, van Doornum GJ, et al. A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients. J Infect Dis. 2008;97:292-294. (Pubitemid 351263450)
32. Winter AP, Follett EA, McIntyre J, et al. Influence of smoking on immunological responses to hepatitis B vaccine. Vaccine. 1994;12:771-772. (Pubitemid 24190555)
33. Weber DJ, Rutala WA, Samsa GP, et al. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA. 1985;254: 3187-3189. (Pubitemid 16206968)
34. Bloom A, Jackson K, Kiviat A, et al. Repeat hepatitis B vaccination may lead to seroprotection in HIV-infected patients who do not respond to an initial series. J Acquir Immune Defic Syndr. 2009;50:110-113.
35. Choudhury SA, Peters VB. Responses to hepatitis B vaccine boosters in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1995;14:65-67.
36. Lanfrum ML, Hullseik KH, Ganesan A, et al. Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals. AIDS. 2010;24: 545-555.
37. Siberry GK, Coller RJ, Henkle E, et al. Antibody response to hepatitis A immunization among human immunodeficiency virus-infected children and adolescents. Pediatr Infect Dis J. 2008;27:465-468.
38. Launay O, Grabar S, Gordien E, et al. Immunological efficacy of a threedose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC study. J Acquir Immune Defic Syndr. 2008;49:272-275.
39. Weinberg A, Huang S, Fenton T, et al. Virologic and immunologic correlates with the magnitude of antibody response to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment. J Acquir Immune Defic Syndr. 2009;52:17-24.